Sentrian, which calls itself “the first remote patient intelligence company,” has raised $12 million in financing including $4 million in seed funding, and $8 million in recent Series A round led by Reed Elsevier Ventures, Frost Data Capital and TELUS Ventures.
Sentrian’s platform is currently being tested by large health insurance plans in controlled studies involving thousands of patients.The Aliso Viejo, California-based company provides a cloud-based remote patient monitoring and analytics platform that promises to reduce preventable hospital admissions. Its solution relies on remote biosensors and machine learning to detect patient deterioration early, before it becomes acute.
“Millions of unnecessary hospitalizations that endanger patients and cost tens of billions of dollars every year could be avoided if we could spot deterioration in patients’ health earlier using remote patient monitoring analytics,” said Dean Sawyer, Co-Founder and CEO of Sentrian.
In addition to Sawyer, who is a former senior executive of Allscripts and Physicians Interactive, Sentrian’s leadership team includes Martin Kohn, MD, MS, FACEP, a world-renowned expert in healthcare population analytics and former CMS for Care Delivery Systems in IBM Research.
Sentrian’s platform is currently being tested by large health insurance plans in controlled studies involving thousands of patients. The company expects to announce the results of those studies at some point next year..